Switch theme
Sign up to access all valuation multiples
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
2004
140
LTM Revenue $59.6M
LTM EBITDA -$2.9M
$138M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
LENSAR has a last 12-month revenue (LTM) of $59.6M and a last 12-month EBITDA of -$2.9M.
In the most recent fiscal year, LENSAR achieved revenue of $53.5M and an EBITDA of -$3.0M.
LENSAR expects next 12-month revenue of XXX and NTM EBITDA of XXX
See LENSAR valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $59.6M | XXX | $53.5M | XXX | XXX | XXX |
| Gross Profit | $29.2M | XXX | $25.9M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | -$2.9M | XXX | -$3.0M | XXX | XXX | XXX |
| EBITDA Margin | -5% | XXX | -6% | XXX | XXX | XXX |
| EBIT | -$8.3M | XXX | -$6.9M | XXX | XXX | XXX |
| EBIT Margin | -14% | XXX | -13% | XXX | XXX | XXX |
| Net Profit | -$20.3M | XXX | -$31.4M | XXX | XXX | XXX |
| Net Margin | -34% | XXX | -59% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, LENSAR's stock price is $14.
LENSAR has current market cap of $161M, and EV of $138M.
See LENSAR trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $138M | $161M | XXX | XXX | XXX | XXX | $-1.76 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, LENSAR has market cap of $161M and EV of $138M.
LENSAR's trades at 2.6x EV/Revenue multiple, and -46.1x EV/EBITDA.
Equity research analysts estimate LENSAR's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
LENSAR has a P/E ratio of -7.9x.
See valuation multiples for LENSAR and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $161M | XXX | $161M | XXX | XXX | XXX |
| EV (current) | $138M | XXX | $138M | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | -48.2x | XXX | -46.1x | XXX | XXX | XXX |
| EV/EBIT | -16.6x | XXX | -20.0x | XXX | XXX | XXX |
| EV/Gross Profit | 4.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -7.9x | XXX | -5.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -56.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLENSAR's last 12 month revenue growth is 28%
LENSAR's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
LENSAR's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LENSAR's rule of X is 66% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for LENSAR and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 28% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Margin | -5% | XXX | -6% | XXX | XXX | XXX |
| EBITDA Growth | -133% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 8% | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LENSAR acquired XXX companies to date.
Last acquisition by LENSAR was XXXXXXXX, XXXXX XXXXX XXXXXX . LENSAR acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was LENSAR founded? | LENSAR was founded in 2004. |
| Where is LENSAR headquartered? | LENSAR is headquartered in United States of America. |
| How many employees does LENSAR have? | As of today, LENSAR has 140 employees. |
| Who is the CEO of LENSAR? | LENSAR's CEO is Mr. Nicholas T. Curtis. |
| Is LENSAR publicy listed? | Yes, LENSAR is a public company listed on NAS. |
| What is the stock symbol of LENSAR? | LENSAR trades under LNSR ticker. |
| When did LENSAR go public? | LENSAR went public in 2020. |
| Who are competitors of LENSAR? | Similar companies to LENSAR include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of LENSAR? | LENSAR's current market cap is $161M |
| What is the current revenue of LENSAR? | LENSAR's last 12 months revenue is $59.6M. |
| What is the current revenue growth of LENSAR? | LENSAR revenue growth (NTM/LTM) is 28%. |
| What is the current EV/Revenue multiple of LENSAR? | Current revenue multiple of LENSAR is 2.3x. |
| Is LENSAR profitable? | Yes, LENSAR is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LENSAR? | LENSAR's last 12 months EBITDA is -$2.9M. |
| What is LENSAR's EBITDA margin? | LENSAR's last 12 months EBITDA margin is -5%. |
| What is the current EV/EBITDA multiple of LENSAR? | Current EBITDA multiple of LENSAR is -48.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
